Decheng Capital Global Life Sciences Fund IV, L.P. bought CGON
January 29, 2024 · Form 4 insider transaction
Decheng Capital Global Life Sciences Fund IV, L.P. bought 400,000 shares of CG Oncology, Inc. at $19.00 per share, a transaction worth $7.60M. The trade was recorded as open-market purchase and disclosed on an SEC Form 4, filed 2 days after the transaction.
Footnotes
These securities are held directly by Decheng Capital Global Healthcare Fund (Master), LP ("Healthcare"). Decheng Capital Global Healthcare GP, LLC ("Healthcare GP") is the general partner of Healthcare. Xiangmin Cui is the manager of Healthcare GP. Each of Healthcare GP and Dr. Cui may be deemed to beneficially own the securities held by Healthcare. Each of Healthcare GP and Dr. Cui disclaims beneficial ownership of these securities, except to the extent of its or his proportionate pecuniary interest therein.